Oncosurgery

by
Q) A 60-year-old woman is found to have a 3.2 cm pancreatic cystic lesion on MRI. EUS shows internal echogenic material within the cyst cavity. To accurately determine whether this represents mural nodules rather than intraluminal debris, which of the following is the most definitive diagnostic approach?
🔒 This answer and explanation are available to Premium Members only.
👉 Upgrade to Premium to access full content.

Bone tumors

by

Q) A 16 year old boy presents with severe groin pain after kicking a football. Imaging confirms a pelvic fracture. A previous pelvic x-ray performed 2 weeks ago shows a lytic lesion with 'onion type' periosteal reaction. What is the lesion?

Question from theme of Test 14

  • a) Giant cell tumor
  • b) Ewing's
  • c) Osteosarcoma
  • d) Osteomalacia
This is a premium question. Click here to access all answers ›

Pancoast tumor

by
Pancoast tumor
Q) 50 year old male with NSCL carcinoma of upper right lung which infiltrates the brachial plexus. What will be the management?

Lung and Thorax MCQs
🔒 This answer and explanation are available to Premium Members only.
👉 Upgrade to Premium to access full content.

Staging in Adenocarcinoma lung

by

Q) Patient with 2cm lung nodule , biopsy proven adenocarcinoma. CT shows hilar lymph node 1.5cm and left pleural effusion. Pleural fluid cytology is positive for malignant cells. What is the stage?

a. T1N1M0
b. T1N2M1
c. T4N1M0
d. T1N1M1

 

Hereditary pancreatic cancers

by

Hereditary pancreatic cancers questions is asked many times in NEET SS and GI and onco Surgery CET 

Please understand the difference between x% lifetime risk of pancreatic cancer and x fold increase in risk as compared to normal population

  1. PRSS & SPINK 1 - Familial pancreatitis 40% lifetime increase . 50 fold increase as compared to Normal
  2. STK 11 - Peutz Jeghers - 100 fold increase in Pancreatic cancer . Also associated with lung, ovarian, breast, uterine, and testicular cancers
  3.  CFTR - cystic fibrosis - 30 fold increase
  4. Familial atypical mole and multiple melanoma syndrome (CDKN2A gene mutation). CDKN2A - 20 fold increase
  5.  BRCA 2 - 10 fold increase
  6. Lynch Syndrome  ( MLH) ( MSH) - 8 fold increase
  7. FAP APC gene - 4 fold

Copyrite. Mcqsurgery 2025